Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Positive [.

European journal of nuclear medicine and molecular imaging

Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, Verburg FA.
PMID: 34223953
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):410-411. doi: 10.1007/s00259-021-05458-1. Epub 2021 Jul 05.

No abstract available.

Cite
Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, et al. Positive [. Eur J Nucl Med Mol Imaging. 2021;49(1):410-411doi: 10.1007/s00259-021-05458-1.
Veldhuijzen van Zanten, S. E. M., Neggers, S. J. C. M. M., Valkema, R., & Verburg, F. A. (2021). Positive [. European journal of nuclear medicine and molecular imaging, 49(1), 410-411. https://doi.org/10.1007/s00259-021-05458-1
Veldhuijzen van Zanten, Sophie E M, et al. "Positive [." European journal of nuclear medicine and molecular imaging vol. 49,1 (2021): 410-411. doi: https://doi.org/10.1007/s00259-021-05458-1
Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, Verburg FA. Positive [. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):410-411. doi: 10.1007/s00259-021-05458-1. Epub 2021 Jul 05. PMID: 34223953.
Copy Download .nbib Format: NLM
Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study.

Neuro-oncology advances

Meijer AJM, Fiocco MF, Janssens GO, Clemens E, Tissing WJE, Loonen JJ, van Dulmen-den Broeder E, de Vries ACH, Bresters D, Versluys B, Ronckers CM, Kremer LCM, van der Pal HJ, Neggers SJCMM, van der Heiden-van der Loo M, Stokroos RJ, Hoetink AE, van Grotel M, van den Heuvel-Eibrink MM.
PMID: 33196041
Neurooncol Adv. 2020 Sep 15;2(1):vdaa122. doi: 10.1093/noajnl/vdaa122. eCollection 2020.

BACKGROUND: Tinnitus is a serious late effect of childhood cancer treatment. The aim of this study was to determine the occurrence and risk factors for tinnitus in a national cohort of childhood cancer survivors (CCS).METHODS: Data were collected within...

Cite
Meijer AJM, Fiocco MF, Janssens GO, et al. Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study. Neurooncol Adv. 2020;2(1):vdaa122doi: 10.1093/noajnl/vdaa122.
Meijer, A. J. M., Fiocco, M. F., Janssens, G. O., Clemens, E., Tissing, W. J. E., Loonen, J. J., van Dulmen-den Broeder, E., de Vries, A. C. H., Bresters, D., Versluys, B., Ronckers, C. M., Kremer, L. C. M., van der Pal, H. J., Neggers, S. J. C. M. M., van der Heiden-van der Loo, M., Stokroos, R. J., Hoetink, A. E., van Grotel, M., & van den Heuvel-Eibrink, M. M. (2020). Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study. Neuro-oncology advances, 2(1), vdaa122. https://doi.org/10.1093/noajnl/vdaa122
Meijer, Annelot J M, et al. "Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study." Neuro-oncology advances vol. 2,1 (2020): vdaa122. doi: https://doi.org/10.1093/noajnl/vdaa122
Meijer AJM, Fiocco MF, Janssens GO, Clemens E, Tissing WJE, Loonen JJ, van Dulmen-den Broeder E, de Vries ACH, Bresters D, Versluys B, Ronckers CM, Kremer LCM, van der Pal HJ, Neggers SJCMM, van der Heiden-van der Loo M, Stokroos RJ, Hoetink AE, van Grotel M, van den Heuvel-Eibrink MM. Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study. Neurooncol Adv. 2020 Sep 15;2(1):vdaa122. doi: 10.1093/noajnl/vdaa122. eCollection 2020. PMID: 33196041; PMCID: PMC7648591.
Copy Download .nbib Format: NLM
Vitamin D supplementation for children with cancer: A systematic review and consensus recommendations.

Cancer medicine

van Atteveld JE, Verhagen IE, van den Heuvel-Eibrink MM, van Santen HM, van der Sluis IM, Di Iorgi N, Simmons JH, Ward LM, Neggers SJCMM.
PMID: 34100559
Cancer Med. 2021 Jul;10(13):4177-4194. doi: 10.1002/cam4.4013. Epub 2021 Jun 08.

BACKGROUND: Prevalent vitamin D deficiency (VDD) and low bone mineral density (BMD) have led to vitamin D supplementation for children with cancer, regardless vitamin D status. However, it remains unsettled whether this enhances bone strength. We sought to address...

Cite
van Atteveld JE, Verhagen IE, van den Heuvel-Eibrink MM, et al. Vitamin D supplementation for children with cancer: A systematic review and consensus recommendations. Cancer Med. 2021;10(13):4177-4194doi: 10.1002/cam4.4013.
van Atteveld, J. E., Verhagen, I. E., van den Heuvel-Eibrink, M. M., van Santen, H. M., van der Sluis, I. M., Di Iorgi, N., Simmons, J. H., Ward, L. M., & Neggers, S. J. C. M. M. (2021). Vitamin D supplementation for children with cancer: A systematic review and consensus recommendations. Cancer medicine, 10(13), 4177-4194. https://doi.org/10.1002/cam4.4013
van Atteveld, Jenneke E, et al. "Vitamin D supplementation for children with cancer: A systematic review and consensus recommendations." Cancer medicine vol. 10,13 (2021): 4177-4194. doi: https://doi.org/10.1002/cam4.4013
van Atteveld JE, Verhagen IE, van den Heuvel-Eibrink MM, van Santen HM, van der Sluis IM, Di Iorgi N, Simmons JH, Ward LM, Neggers SJCMM. Vitamin D supplementation for children with cancer: A systematic review and consensus recommendations. Cancer Med. 2021 Jul;10(13):4177-4194. doi: 10.1002/cam4.4013. Epub 2021 Jun 08. PMID: 34100559; PMCID: PMC8267124.
Copy Download .nbib Format: NLM
Positive [.

European journal of nuclear medicine and molecular imaging

Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, Verburg FA.
PMID: 34223953
Eur J Nucl Med Mol Imaging. 2021 Jul 05; doi: 10.1007/s00259-021-05458-1. Epub 2021 Jul 05.

No abstract available.

Cite
Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, et al. Positive [. Eur J Nucl Med Mol Imaging. 2021;doi: 10.1007/s00259-021-05458-1.
Veldhuijzen van Zanten, S. E. M., Neggers, S. J. C. M. M., Valkema, R., & Verburg, F. A. (2021). Positive [. European journal of nuclear medicine and molecular imaging, . https://doi.org/10.1007/s00259-021-05458-1
Veldhuijzen van Zanten, Sophie E M, et al. "Positive [." European journal of nuclear medicine and molecular imaging vol. (2021). doi: https://doi.org/10.1007/s00259-021-05458-1
Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, Verburg FA. Positive [. Eur J Nucl Med Mol Imaging. 2021 Jul 05; doi: 10.1007/s00259-021-05458-1. Epub 2021 Jul 05. PMID: 34223953.
Copy Download .nbib Format: NLM
Unacylated ghrelin binds heparan-sulfate proteoglycans which modulate its function.

Journal of molecular endocrinology

Delhanty PJD, Huisman M, Prins K, Steenbergen C, Mies R, Neggers SJCMM, van der Lely AJ, Visser JA.
PMID: 33263557
J Mol Endocrinol. 2021 Feb;66(2):83-96. doi: 10.1530/JME-20-0286.

Acylated ghrelin (AG) is a gut-derived peptide with growth hormone secretagogue (GHS), orexigenic and other physiological activities mediated by GHS receptor-1a (GHSR). Ghrelin occurs in unacylated form (UAG) with activities opposing AG, although its mechanism of action is unknown....

Cite
Delhanty PJD, Huisman M, Prins K, et al. Unacylated ghrelin binds heparan-sulfate proteoglycans which modulate its function. J Mol Endocrinol. 2021;66(2):83-96doi: 10.1530/JME-20-0286.
Delhanty, P. J. D., Huisman, M., Prins, K., Steenbergen, C., Mies, R., Neggers, S. J. C. M. M., van der Lely, A. J., & Visser, J. A. (2021). Unacylated ghrelin binds heparan-sulfate proteoglycans which modulate its function. Journal of molecular endocrinology, 66(2), 83-96. https://doi.org/10.1530/JME-20-0286
Delhanty, Patric J D, et al. "Unacylated ghrelin binds heparan-sulfate proteoglycans which modulate its function." Journal of molecular endocrinology vol. 66,2 (2021): 83-96. doi: https://doi.org/10.1530/JME-20-0286
Delhanty PJD, Huisman M, Prins K, Steenbergen C, Mies R, Neggers SJCMM, van der Lely AJ, Visser JA. Unacylated ghrelin binds heparan-sulfate proteoglycans which modulate its function. J Mol Endocrinol. 2021 Feb;66(2):83-96. doi: 10.1530/JME-20-0286. PMID: 33263557.
Copy Download .nbib Format: NLM
Metabolic syndrome detection with biomarkers in childhood cancer survivors.

Endocrine connections

Pluimakers VG, van Waas M, Looman CWN, de Maat MP, de Jonge R, Delhanty P, Huisman M, Mattace-Raso FUS, van den Heuvel-Eibrink MM, Neggers SJCMM.
PMID: 32567553
Endocr Connect. 2020 Jul;9(7):676-686. doi: 10.1530/EC-20-0144.

PURPOSE: Augmented survival of childhood nephroblastoma and neuroblastoma has increased long-term side effects such as metabolic syndrome (MetS). Risk stratification is difficult after abdominal radiation because waist circumference underestimates adiposity. We aimed to develop a strategy for determining MetS...

Cite
Pluimakers VG, van Waas M, Looman CWN, et al. Metabolic syndrome detection with biomarkers in childhood cancer survivors. Endocr Connect. 2020;9(7):676-686doi: 10.1530/EC-20-0144.
Pluimakers, V. G., van Waas, M., Looman, C. W. N., de Maat, M. P., de Jonge, R., Delhanty, P., Huisman, M., Mattace-Raso, F. U. S., van den Heuvel-Eibrink, M. M., & Neggers, S. J. C. M. M. (2020). Metabolic syndrome detection with biomarkers in childhood cancer survivors. Endocrine connections, 9(7), 676-686. https://doi.org/10.1530/EC-20-0144
Pluimakers, V G, et al. "Metabolic syndrome detection with biomarkers in childhood cancer survivors." Endocrine connections vol. 9,7 (2020): 676-686. doi: https://doi.org/10.1530/EC-20-0144
Pluimakers VG, van Waas M, Looman CWN, de Maat MP, de Jonge R, Delhanty P, Huisman M, Mattace-Raso FUS, van den Heuvel-Eibrink MM, Neggers SJCMM. Metabolic syndrome detection with biomarkers in childhood cancer survivors. Endocr Connect. 2020 Jul;9(7):676-686. doi: 10.1530/EC-20-0144. PMID: 32567553; PMCID: PMC7424353.
Copy Download .nbib Format: NLM
Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study.

The Journal of clinical endocrinology and metabolism

van Santen SS, Wolf P, Kremenevski N, Boguszewski CL, Beiglböck H, Fiocco M, Wijnen M, Wallenius VR, van den Heuvel-Eibrink MM, van der Lely AJ, Johannsson G, Luger A, Krebs M, Buchfelder M, Delhanty PJD, Neggers SJCMM, Olsson DS.
PMID: 34265053
J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4734-e4745. doi: 10.1210/clinem/dgab518.

CONTEXT: Craniopharyngioma is a sellar tumor associated with high rates of pituitary deficiencies (~ 98%) and hypothalamic obesity (~ 50%).OBJECTIVE: This work aims to determine the efficacy regarding long-term weight loss after bariatric surgery in obese craniopharyngioma patients with...

Cite
van Santen SS, Wolf P, Kremenevski N, et al. Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study. J Clin Endocrinol Metab. 2021;106(11):e4734-e4745doi: 10.1210/clinem/dgab518.
van Santen, S. S., Wolf, P., Kremenevski, N., Boguszewski, C. L., Beiglböck, H., Fiocco, M., Wijnen, M., Wallenius, V. R., van den Heuvel-Eibrink, M. M., van der Lely, A. J., Johannsson, G., Luger, A., Krebs, M., Buchfelder, M., Delhanty, P. J. D., Neggers, S. J. C. M. M., & Olsson, D. S. (2021). Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study. The Journal of clinical endocrinology and metabolism, 106(11), e4734-e4745. https://doi.org/10.1210/clinem/dgab518
van Santen, Selveta S, et al. "Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study." The Journal of clinical endocrinology and metabolism vol. 106,11 (2021): e4734-e4745. doi: https://doi.org/10.1210/clinem/dgab518
van Santen SS, Wolf P, Kremenevski N, Boguszewski CL, Beiglböck H, Fiocco M, Wijnen M, Wallenius VR, van den Heuvel-Eibrink MM, van der Lely AJ, Johannsson G, Luger A, Krebs M, Buchfelder M, Delhanty PJD, Neggers SJCMM, Olsson DS. Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study. J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4734-e4745. doi: 10.1210/clinem/dgab518. PMID: 34265053; PMCID: PMC8530717.
Copy Download .nbib Format: NLM
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study.

NPJ precision oncology

Meijer AJM, Diepstraten FA, Langer T, Broer L, Domingo IK, Clemens E, Uitterlinden AG, de Vries ACH, van Grotel M, Vermeij WP, Ozinga RA, Binder H, Byrne J, van Dulmen-den Broeder E, Garrè ML, Grabow D, Kaatsch P, Kaiser M, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, Kepakova K, Tissing WJE, van der Kooi ALF, Kremer LCM, Kruseova J, Pluijm SMF, Kuehni CE, van der Pal HJH, Parfitt R, Spix C, Tillmanns A, Deuster D, Matulat P, Calaminus G, Hoetink AE, Elsner S, Gebauer J, Haupt R, Lackner H, Blattmann C, Neggers SJCMM, Rassekh SR, Wright GEB, Brooks B, Nagtegaal AP, Drögemöller BI, Ross CJD, Bhavsar AP, Am Zehnhoff-Dinnesen AG, Carleton BC, Zolk O, van den Heuvel-Eibrink MM.
PMID: 34262104
NPJ Precis Oncol. 2021 Jul 14;5(1):64. doi: 10.1038/s41698-021-00178-z.

In children with cancer, the heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility. Using a genome-wide association study (GWAS) approach, we identified a genetic variant in TCERG1L (rs893507) to be associated with hearing loss...

Cite
Meijer AJM, Diepstraten FA, Langer T, et al. TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ Precis Oncol. 2021;5(1):64doi: 10.1038/s41698-021-00178-z.
Meijer, A. J. M., Diepstraten, F. A., Langer, T., Broer, L., Domingo, I. K., Clemens, E., Uitterlinden, A. G., de Vries, A. C. H., van Grotel, M., Vermeij, W. P., Ozinga, R. A., Binder, H., Byrne, J., van Dulmen-den Broeder, E., Garrè, M. L., Grabow, D., Kaatsch, P., Kaiser, M., Kenborg, L., Winther, J. F., Rechnitzer, C., Hasle, H., Kepak, T., Kepakova, K., Tissing, W. J. E., van der Kooi, A. L. F., Kremer, L. C. M., Kruseova, J., Pluijm, S. M. F., Kuehni, C. E., van der Pal, H. J. H., Parfitt, R., Spix, C., Tillmanns, A., Deuster, D., Matulat, P., Calaminus, G., Hoetink, A. E., Elsner, S., Gebauer, J., Haupt, R., Lackner, H., Blattmann, C., Neggers, S. J. C. M. M., Rassekh, S. R., Wright, G. E. B., Brooks, B., Nagtegaal, A. P., Drögemöller, B. I., Ross, C. J. D., Bhavsar, A. P., Am Zehnhoff-Dinnesen, A. G., Carleton, B. C., Zolk, O., van den Heuvel-Eibrink, M. M. (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ precision oncology, 5(1), 64. https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, et al. "TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study." NPJ precision oncology vol. 5,1 (2021): 64. doi: https://doi.org/10.1038/s41698-021-00178-z
Meijer AJM, Diepstraten FA, Langer T, Broer L, Domingo IK, Clemens E, Uitterlinden AG, de Vries ACH, van Grotel M, Vermeij WP, Ozinga RA, Binder H, Byrne J, van Dulmen-den Broeder E, Garrè ML, Grabow D, Kaatsch P, Kaiser M, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, Kepakova K, Tissing WJE, van der Kooi ALF, Kremer LCM, Kruseova J, Pluijm SMF, Kuehni CE, van der Pal HJH, Parfitt R, Spix C, Tillmanns A, Deuster D, Matulat P, Calaminus G, Hoetink AE, Elsner S, Gebauer J, Haupt R, Lackner H, Blattmann C, Neggers SJCMM, Rassekh SR, Wright GEB, Brooks B, Nagtegaal AP, Drögemöller BI, Ross CJD, Bhavsar AP, Am Zehnhoff-Dinnesen AG, Carleton BC, Zolk O, van den Heuvel-Eibrink MM. TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ Precis Oncol. 2021 Jul 14;5(1):64. doi: 10.1038/s41698-021-00178-z. PMID: 34262104; PMCID: PMC8280110.
Copy Download .nbib Format: NLM
Positive [.

European journal of nuclear medicine and molecular imaging

Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, Verburg FA.
PMID: 34223953
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):410-411. doi: 10.1007/s00259-021-05458-1. Epub 2021 Jul 05.

No abstract available.

Cite
Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, et al. Positive [. Eur J Nucl Med Mol Imaging. 2021;49(1):410-411doi: 10.1007/s00259-021-05458-1.
Veldhuijzen van Zanten, S. E. M., Neggers, S. J. C. M. M., Valkema, R., & Verburg, F. A. (2021). Positive [. European journal of nuclear medicine and molecular imaging, 49(1), 410-411. https://doi.org/10.1007/s00259-021-05458-1
Veldhuijzen van Zanten, Sophie E M, et al. "Positive [." European journal of nuclear medicine and molecular imaging vol. 49,1 (2021): 410-411. doi: https://doi.org/10.1007/s00259-021-05458-1
Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, Verburg FA. Positive [. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):410-411. doi: 10.1007/s00259-021-05458-1. Epub 2021 Jul 05. PMID: 34223953.
Copy Download .nbib Format: NLM
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors.

Endocrine reviews

van Iersel L, Mulder RL, Denzer C, Cohen LE, Spoudeas HA, Meacham LR, Sugden E, Schouten-van Meeteren AYN, Hoving EW, Packer RJ, Armstrong GT, Mostoufi-Moab S, Stades AM, van Vuurden D, Janssens GO, Thomas-Teinturier C, Murray RD, Di Iorgi N, Neggers SJCMM, Thompson J, Toogood AA, Gleeson H, Follin C, Bardi E, Torno L, Patterson B, Morsellino V, Sommer G, Clement SC, Srivastava D, Kiserud CE, Fernandez A, Scheinemann K, Raman S, Yuen KCJ, Wallace WH, Constine LS, Skinner R, Hudson MM, Kremer LCM, Chemaitilly W, van Santen HM.
PMID: 34962573
Endocr Rev. 2021 Nov 20; doi: 10.1210/endrev/bnab040. Epub 2021 Nov 20.

Endocrine disorders in survivors of childhood, adolescent, and young adult (CAYA) cancers are associated with substantial adverse physical and psychosocial effects. To improve appropriate and timely endocrine screening and referral to a specialist, the International Late Effects of Childhood...

Cite
van Iersel L, Mulder RL, Denzer C, et al. Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors. Endocr Rev. 2021;doi: 10.1210/endrev/bnab040.
van Iersel, L., Mulder, R. L., Denzer, C., Cohen, L. E., Spoudeas, H. A., Meacham, L. R., Sugden, E., Schouten-van Meeteren, A. Y. N., Hoving, E. W., Packer, R. J., Armstrong, G. T., Mostoufi-Moab, S., Stades, A. M., van Vuurden, D., Janssens, G. O., Thomas-Teinturier, C., Murray, R. D., Di Iorgi, N., Neggers, S. J. C. M. M., Thompson, J., Toogood, A. A., Gleeson, H., Follin, C., Bardi, E., Torno, L., Patterson, B., Morsellino, V., Sommer, G., Clement, S. C., Srivastava, D., Kiserud, C. E., Fernandez, A., Scheinemann, K., Raman, S., Yuen, K. C. J., Wallace, W. H., Constine, L. S., Skinner, R., Hudson, M. M., Kremer, L. C. M., Chemaitilly, W., & van Santen, H. M. (2021). Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors. Endocrine reviews, . https://doi.org/10.1210/endrev/bnab040
van Iersel, Laura, et al. "Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors." Endocrine reviews vol. (2021). doi: https://doi.org/10.1210/endrev/bnab040
van Iersel L, Mulder RL, Denzer C, Cohen LE, Spoudeas HA, Meacham LR, Sugden E, Schouten-van Meeteren AYN, Hoving EW, Packer RJ, Armstrong GT, Mostoufi-Moab S, Stades AM, van Vuurden D, Janssens GO, Thomas-Teinturier C, Murray RD, Di Iorgi N, Neggers SJCMM, Thompson J, Toogood AA, Gleeson H, Follin C, Bardi E, Torno L, Patterson B, Morsellino V, Sommer G, Clement SC, Srivastava D, Kiserud CE, Fernandez A, Scheinemann K, Raman S, Yuen KCJ, Wallace WH, Constine LS, Skinner R, Hudson MM, Kremer LCM, Chemaitilly W, van Santen HM. Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors. Endocr Rev. 2021 Nov 20; doi: 10.1210/endrev/bnab040. Epub 2021 Nov 20. PMID: 34962573.
Copy Download .nbib Format: NLM
Positive [.

European journal of nuclear medicine and molecular imaging

Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, Verburg FA.
PMID: 34223953
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):410-411. doi: 10.1007/s00259-021-05458-1. Epub 2021 Jul 05.

No abstract available.

Cite
Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, et al. Positive [. Eur J Nucl Med Mol Imaging. 2021;49(1):410-411doi: 10.1007/s00259-021-05458-1.
Veldhuijzen van Zanten, S. E. M., Neggers, S. J. C. M. M., Valkema, R., & Verburg, F. A. (2021). Positive [. European journal of nuclear medicine and molecular imaging, 49(1), 410-411. https://doi.org/10.1007/s00259-021-05458-1
Veldhuijzen van Zanten, Sophie E M, et al. "Positive [." European journal of nuclear medicine and molecular imaging vol. 49,1 (2021): 410-411. doi: https://doi.org/10.1007/s00259-021-05458-1
Veldhuijzen van Zanten SEM, Neggers SJCMM, Valkema R, Verburg FA. Positive [. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):410-411. doi: 10.1007/s00259-021-05458-1. Epub 2021 Jul 05. PMID: 34223953; PMCID: PMC8712289.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries